• Return to Headlines

Shares of Endocyte Inc Rank the Lowest in Terms of Revenue Per Employee in the Pharmaceuticals Industry (ECYT, RVNC, ITCI, OCUL, DERM)

By Shiri Gupta

Below are the three companies in the Pharmaceuticals industry with the lowest Revenue Per Employee (RPE). Analysts use RPE as a measure to compare the productivity of companies in the same industry.

Endocyte Inc ranks lowest with a an RPE of $2,000. Revance Therapeu is next with a an RPE of $3,000. Intra-Cellular T ranks third lowest with a an RPE of $3,000.

Ocular Therapeut follows with a an RPE of $15,000, and Dermira rounds out the bottom five with a an RPE of $23,000.

SmarTrend recommended that subscribers consider buying shares of Dermira on October 21st, 2019 as our technology indicated a new Uptrend was in progress when shares hit $7.18. Since that recommendation, shares of Dermira have risen 9.8%. We continue to monitor Dermira for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: lowest revenue per employee endocyte inc revance therapeu intra-cellular t ocular therapeut dermira

Ticker(s): ECYT RVNC ITCI OCUL DERM